470 related articles for article (PubMed ID: 11454708)
1. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
2. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
[TBL] [Abstract][Full Text] [Related]
3. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart.
Asundi VK; Keister BF; Stahl RC; Carey DJ
Exp Cell Res; 1997 Jan; 230(1):145-53. PubMed ID: 9013716
[TBL] [Abstract][Full Text] [Related]
4. Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes.
Bansal R; Kumar M; Murray K; Pfeiffer SE
Mol Cell Neurosci; 1996 Apr; 7(4):276-88. PubMed ID: 8793863
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
[TBL] [Abstract][Full Text] [Related]
6. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain.
Saunders S; Paine-Saunders S; Lander AD
Dev Biol; 1997 Oct; 190(1):78-93. PubMed ID: 9331333
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
Delehedde M; Deudon E; Boilly B; Hondermarck H
Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
[TBL] [Abstract][Full Text] [Related]
9. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
Kleeff J; Ishiwata T; Kumbasar A; Friess H; Büchler MW; Lander AD; Korc M
J Clin Invest; 1998 Nov; 102(9):1662-73. PubMed ID: 9802880
[TBL] [Abstract][Full Text] [Related]
10. Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells.
Li J; Kleeff J; Kayed H; Felix K; Penzel R; Büchler MW; Korc M; Friess H
Biochem Biophys Res Commun; 2004 Aug; 320(4):1148-55. PubMed ID: 15249209
[TBL] [Abstract][Full Text] [Related]
11. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells.
Kleeff J; Wildi S; Kumbasar A; Friess H; Lander AD; Korc M
Pancreas; 1999 Oct; 19(3):281-8. PubMed ID: 10505759
[TBL] [Abstract][Full Text] [Related]
12. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
14. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
15. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
Yamagata E; Kamada A
J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
[TBL] [Abstract][Full Text] [Related]
18. Expression of proteoglycan core proteins in human bone marrow stroma.
Schofield KP; Gallagher JT; David G
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells.
Sun H; Berquin IM; Edwards IJ
Cancer Res; 2005 May; 65(10):4442-7. PubMed ID: 15899837
[TBL] [Abstract][Full Text] [Related]
20. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent.
Litwack ED; Ivins JK; Kumbasar A; Paine-Saunders S; Stipp CS; Lander AD
Dev Dyn; 1998 Jan; 211(1):72-87. PubMed ID: 9438425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
